After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a…
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Life
Extinct relative of koalas discovered in Western Australia
News
Physics
The 50-year quest to create a quantum spin liquid may finally be over
Features
Technology
Backlash builds over NHS plan to hide source code from AI hacking risk
News
ÎçÒ¹¸£Àû1000¼¯ºÏ
Hantavirus: Where has the deadly cruise ship outbreak come from?
News
Popular articles
Trending New Scientist articles
1
Man destined to get Alzheimer’s saved by accidental heat therapy
2
Woman in cancer remission without treatment in highly unusual case
3
A lost ancient script reveals how writing as we know it really began
4
Extinct relative of koalas discovered in Western Australia
5
Hantavirus: Where has the deadly cruise ship outbreak come from?
6
We have figured out a new way to send messages into the past
7
Honey has been used as medicine for centuries – does it really work?
8
Exercise helps fight cancer – and we may finally know why
9
The 50-year quest to create a quantum spin liquid may finally be over
10
Weird 'transdimensional' state of matter is neither 2D nor 3D
